Gene: LYPD5
Official Full Name: LY6/PLAUR domain containing 5provided by HGNC
Gene Summary: Predicted to be located in extracellular region. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16405 | LYPD5 Knockout cell line (HCT 116) | Human | LYPD5 | 1:2~1:4 | Negative | Online Inquiry |
LYPD5 Gene Knockout Cell Lines represent a significant advancement in the field of molecular biology and genetic research. These cell lines are specifically engineered to have the LYPD5 gene disrupted, allowing researchers to study the implications of LYPD5 dysfunction in various biological processes more effectively. The precise knockout of this gene is facilitated through cutting-edge CRISPR/Cas9 technology, ensuring high specificity and efficiency, resulting in homogenous cell populations.
The primary function of LYPD5 involves its role in mediating cellular signaling pathways and influencing immune responses. By utilizing these knockout cell lines, scientists can unravel the molecular mechanisms underlying LYPD5’s impact on cellular functions such as proliferation, cytokine production, and tissue homeostasis. The knockout models facilitate the direct observation of phenotypic changes and biochemical pathways affected by LYPD5 silencing, paving the way for innovative therapeutic strategies targeting related diseases.
In research settings, LYPD5 Gene Knockout Cell Lines hold immense promise for the investigation of autoimmune disorders, inflammatory diseases, and cellular senescence, thereby providing insights into the development of targeted therapies. Clinically, these models can accelerate drug development processes by simulating disease conditions in vitro, enabling high-throughput screening of potential candidates.
One of the standout advantages of our LYPD5 Gene Knockout Cell Lines is the reliability and reproducibility they offer, which are critical for obtaining validated and consistent experimental results. Unlike alternatives that rely on gene silencing techniques such as siRNA, these knockout lines provide a stable genomic change that can lead to more robust research findings over time.
The value of our LYPD5 Gene Knockout Cell Lines extends to researchers and clinicians alike, as they not only enhance the accuracy of experimental models but also contribute to an enriched understanding of LYPD5-related functions in a therapeutic context. They are indispensable tools for advancing scientific knowledge and improving patient outcomes.
Our company boasts a wealth of experience in producing high-quality, genetically engineered cell lines tailored for specific research needs. We are committed to delivering exceptional products that empower the scientific community in their quest for discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.